Comparison of Cinnarizine/Dimenhydrinate Fixed Combination with the Respective Monotherapies for Vertigo of Various OriginsA Randomized, Double-Blind, Active-Controlled, Multicentre Study

被引：0
|
作者：
Ales Hahn
Miroslav Novotný
Penko M. Shotekov
Zdenek Cirek
Irene Bognar-Steinberg
Wolfgang Baumann
机构：
[1] Charles University Prague,ENT Department
[2] Third Medical Faculty and Faculty Hospital Královské Vinohrady,ENT Clinic
[3] Masaryk University,First Neurological Clinic
[4] Medical Academy,ENT Clinic
[5] Charles University,Department of Clinical Research
[6] Hennig Arzneimittel,undefined
来源：
Clinical Drug Investigation | 2011年 / 31卷
关键词：
Fixed Combination; Benign Paroxysmal Positional Vertigo; Cinnarizine; Dimenhydrinate; Vestibular Disorder;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background and Objective: Vertigo may arise from dysfunction in the peripheral and/or the central vestibular system. Simultaneous activity of a medication at both sites will serve to improve the efficacy of antivertigo treatment. The aim of this study was to compare the efficacy and tolerability of a fixed combination of the peripherally acting cinnarizine (20 mg) plus the centrally acting dimenhydrinate (40 mg) with those of equally dosed monotherapies in the treatment of vertigo of various origins.
引用
收藏
页码：371 / 383
页数：12
相关论文
共 50 条
  • [41] Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial
    Scholtz, Arne W.
    Hahn, Ales
    Stefflova, Bohdana
    Medzhidieva, Daniela
    Ryazantsev, Sergey V.
    Paschinin, Alexander
    Kunelskaya, Natalia
    Schumacher, Kai
    Weisshaar, Gerhard
    CLINICAL DRUG INVESTIGATION, 2019, 39 (11) : 1045 - 1056
  • [42] Efficacy and safety of Elagolix in endometriosis: Phase-III randomized double-blind active-controlled trial
    Gupta, N.
    Palve, T.
    Kamilya, G.
    Srivastava, S.
    Malathi, P.
    Bohir, S.
    Patel, J. S.
    Dash, M. K.
    Saigal, S.
    Savalia, K. P.
    Gupta, T.
    Chaudhary, D.
    Manohar, R.
    Shah, P.
    Bhat, V. V.
    Shetty, A.
    Saha, S.
    Quadros, R.
    Patil, D.
    Patel, P.
    Ghadge, P.
    Mane, A.
    Mehta, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 3 - 3
  • [43] Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial
    Luigi Alberto Pini
    Simona Guerzoni
    Maria Michela Cainazzo
    Anna Ferrari
    Paola Sarchielli
    Ilaria Tiraferri
    Michela Ciccarese
    Maurizio Zappaterra
    The Journal of Headache and Pain, 2012, 13 : 677 - 684
  • [44] Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study
    Clayton, Anita H.
    Durgam, Suresh
    Li, Dayong
    Chen, Changzheng
    Chen, Laishun
    Mathews, Maju
    Gommoll, Carl P.
    Szegedi, Armin
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (01) : 27 - 35
  • [45] Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial
    Pini, Luigi Alberto
    Guerzoni, Simona
    Cainazzo, Maria Michela
    Ferrari, Anna
    Sarchielli, Paola
    Tiraferri, Ilaria
    Ciccarese, Michela
    Zappaterra, Maurizio
    JOURNAL OF HEADACHE AND PAIN, 2012, 13 (08): : 677 - 684
  • [46] Efficacy and safety of lornoxicam vs ibuprofen in primary dysmenorrhea: a randomized, double-blind, double dummy, active-controlled, cross over study
    Patel, Jayshree C.
    Patel, Parvati B.
    Acharya, Hemangini
    Nakum, Kanaklata
    Tripathi, C. B.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2015, 188 : 118 - 123
  • [47] Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial
    Arne W. Scholtz
    Ales Hahn
    Bohdana Stefflova
    Daniela Medzhidieva
    Sergey V. Ryazantsev
    Alexander Paschinin
    Natalia Kunelskaya
    Kai Schumacher
    Gerhard Weisshaar
    Clinical Drug Investigation, 2019, 39 : 1045 - 1056
  • [48] A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients
    Stricker, Kirstin
    Yu, Sue
    Krammer, Gerhard
    BMC MUSCULOSKELETAL DISORDERS, 2008, 9 (1)
  • [49] A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients
    Kirstin Stricker
    Sue Yu
    Gerhard Krammer
    BMC Musculoskeletal Disorders, 9
  • [50] Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study, a multicentre, randomized, double-blind, active-controlled, phase 3 trial
    Dou, Jingtao
    Ma, Jianhua
    Liu, Jun
    Wang, Changjiang
    Johnsson, Eva
    Yao, Hui
    Zhao, June
    Pan, Changyu
    DIABETES OBESITY & METABOLISM, 2018, 20 (03): : 590 - 598
12345